KOBE UNIVERSITY

KOBE UNIVERSITY logo
🇯🇵Japan
Ownership
Private
Established
1949-01-01
Employees
1K
Market Cap
-
Website
http://www.kobe-u.ac.jp

A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )

First Posted Date
2020-01-09
Last Posted Date
2021-06-03
Lead Sponsor
Kobe University
Target Recruit Count
8
Registration Number
NCT04221152
Locations
🇯🇵

Okayama University Hospital, Okayama, Japan

🇯🇵

NIhon University Hospital, Chiyoda-ku, Tokyo, Japan

🇯🇵

Tohoku University Hospita, Sendai, Miyagi, Japan

and more 2 locations

A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

First Posted Date
2019-07-12
Last Posted Date
2021-03-03
Lead Sponsor
Kobe University
Target Recruit Count
8
Registration Number
NCT04018365
Locations
🇯🇵

Tohoku University Hospital, Sendai, Miyagi, Japan

🇯🇵

Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan

🇯🇵

Okayama University Hospital, Okayama, Japan

and more 2 locations

Evaluation of Fractional Flow Reserve Calculated by Computed Tomography Coronary Angiography in Patients Undergoing TAVR

First Posted Date
2018-09-11
Last Posted Date
2018-09-13
Lead Sponsor
Kobe University
Target Recruit Count
25
Registration Number
NCT03665389

Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

First Posted Date
2018-09-05
Last Posted Date
2018-09-18
Lead Sponsor
Kobe University
Target Recruit Count
75
Registration Number
NCT03657758
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography

First Posted Date
2018-06-11
Last Posted Date
2018-11-14
Lead Sponsor
Kobe University
Target Recruit Count
24
Registration Number
NCT03552432
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization

First Posted Date
2018-05-30
Last Posted Date
2018-05-30
Lead Sponsor
Kobe University
Target Recruit Count
181
Registration Number
NCT03540381
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy

First Posted Date
2018-05-23
Last Posted Date
2018-05-30
Lead Sponsor
Kobe University
Target Recruit Count
31
Registration Number
NCT03533959
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound

First Posted Date
2018-05-18
Last Posted Date
2018-08-31
Lead Sponsor
Kobe University
Target Recruit Count
30
Registration Number
NCT03529253
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial

First Posted Date
2017-06-20
Last Posted Date
2018-01-09
Lead Sponsor
Kobe University
Target Recruit Count
50
Registration Number
NCT03192579

Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography

First Posted Date
2017-01-13
Last Posted Date
2017-01-13
Lead Sponsor
Kobe University
Target Recruit Count
72
Registration Number
NCT03021382
Locations
🇯🇵

Kobe University Graduate School of Medicine, Department of Cardiology, Kobe, Hyogo, Japan

© Copyright 2024. All Rights Reserved by MedPath